We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Symyx Launches Contract Development and Manufacturing Organization for Biopharmaceuticals
News

Symyx Launches Contract Development and Manufacturing Organization for Biopharmaceuticals

Symyx Launches Contract Development and Manufacturing Organization for Biopharmaceuticals
News

Symyx Launches Contract Development and Manufacturing Organization for Biopharmaceuticals

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Symyx Launches Contract Development and Manufacturing Organization for Biopharmaceuticals"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Symyx Technologies, Inc. has announced the launch of the Symyx Contract Development and Manufacturing Organization (CDMO). The Symyx CDMO helps biopharmaceutical companies move promising drug candidates to clinical trials faster and reliably with integrated formulation development, and preclinical and CGMP fill/finish manufacturing.

"After discovery, the next critical milestone in drug development is getting to clinical trials quickly with a reliable formulation. The Symyx CDMO provides clients a faster, more reliable route to clinical trials," said Richard Boehner, president of Symyx High Productivity Research (HPR). “We do this by combining unsurpassed formulation expertise, high-productivity research technology and CGMP clinical manufacturing in a single facility."

With expertise in preformulation development, formulation optimization and stability, and analytical method development, the Symyx CDMO enables development of highly optimized and robust drug formulations, so that clinical trials test the efficacy of drug candidates, not the limitations of the formulation.

In addition, the Symyx CDMO offers full service fill/finish execution for delivering drug products manufactured under CGMP conditions while maintaining the integrity of drug substances and meeting preclinical and Phase I and II clinical trial schedules.
Advertisement